NCT04094948View on ClinicalTrials.gov

Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

January 1, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 30, 2025

Conditions

Pompe Disease (Late-onset)

Interventions

DRUG

Clenbuterol

20 mcg spiropent tablets will be overencapsulated (two 20 mcg tablets per capsule)

DRUG

Placebos

dextrose-filled capsules

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER